• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Fas、Fas配体、免疫耐受与癌症:对结肠癌的影响]

[Fas, fas ligand, immune tolerance, and cancer: implications in cancer of the colon].

作者信息

Berger A, Piqueras B, Pages F, Tartour E, Cugnenc P H, Fridman W H

机构信息

Service de chirurgie générale, digestive et oncologique, Hôpital Laennec, Paris.

出版信息

Bull Cancer. 1998 Feb;85(2):129-33.

PMID:9752329
Abstract

Fas and Fas ligand (FasL) are implicated in programmed cell death or apoptosis. In the immunological field, they are particularly important in auto-immunity, graft rejection and anti-tumoral response. Fas ligand expression on thymocytes, activated T lymphocytes, and in sites of immune privilege, suggests the importance of Fas/FasL interactions in negative control of the immune response. The recent description of FasL expression by tumoral cells, represents a new mechanism of immune escape for different cancer, and has been well studied in colon adenocarcinoma.

摘要

Fas和Fas配体(FasL)与程序性细胞死亡或凋亡有关。在免疫学领域,它们在自身免疫、移植排斥和抗肿瘤反应中尤为重要。胸腺细胞、活化的T淋巴细胞以及免疫豁免部位的Fas配体表达,表明Fas/FasL相互作用在免疫反应的负调控中具有重要意义。肿瘤细胞FasL表达的最新描述,代表了不同癌症免疫逃逸的一种新机制,并且在结肠腺癌中已得到充分研究。

相似文献

1
[Fas, fas ligand, immune tolerance, and cancer: implications in cancer of the colon].[Fas、Fas配体、免疫耐受与癌症:对结肠癌的影响]
Bull Cancer. 1998 Feb;85(2):129-33.
2
Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back.Fas配体(CD95L)在免疫逃逸中的作用:肿瘤细胞反击。
J Immunol. 1997 May 15;158(10):4521-4.
3
Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.人结肠腺癌中FAP-1的表达:对癌症中Fas介导的细胞凋亡抗性的影响。
Br J Cancer. 2004 Nov 1;91(9):1718-25. doi: 10.1038/sj.bjc.6602136.
4
[The role of Fas/Fas ligand in tumorgenesis, immune escape, and counterattack in colonic cancer].
Zhonghua Nei Ke Za Zhi. 2002 Jun;41(6):378-80.
5
Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.解决“Fas反击”争议:阻断Fas配体表达可抑制结肠癌在体内的肿瘤免疫逃逸。
Cancer Res. 2005 Nov 1;65(21):9817-23. doi: 10.1158/0008-5472.CAN-05-1462.
6
On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.以多发性骨髓瘤为模型探讨Fas(Apo-1/CD95)配体(FasL)在免疫赦免组织和癌细胞中表达的作用及意义
Leuk Lymphoma. 1998 Nov;31(5-6):477-90. doi: 10.3109/10428199809057607.
7
Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo.在结肠癌中表达的Fas配体与体内肿瘤细胞凋亡增加无关。
Int J Cancer. 2003 Nov 1;107(2):209-14. doi: 10.1002/ijc.11392.
8
Immune privilege or inflammation? The paradoxical effects of Fas ligand.免疫豁免还是炎症?Fas配体的矛盾效应。
Arch Immunol Ther Exp (Warsz). 2000;48(2):73-9.
9
The Fas/Fas ligand system and cancer: immune privilege and apoptosis.Fas/Fas配体系统与癌症:免疫豁免与细胞凋亡
Mol Biotechnol. 2003 Sep;25(1):19-30. doi: 10.1385/MB:25:1:19.
10
Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.结肠癌中凋亡机制的改变:肿瘤-免疫冲突中的Fas抵抗与反击。
Ann N Y Acad Sci. 2000 Jun;910:178-92; discussion 193-5. doi: 10.1111/j.1749-6632.2000.tb06708.x.